CGHNW - SODIUM IODIDE I 131 DIAGNOSTIC CAPSULES
- MSDS: CGHNW
- Manufacturer: MALLINCKRODT MEDICAL INC
- Product Name: SODIUM IODIDE I 131 DIAGNOSTIC CAPSULES
- National Stock Number: 6505-00F054702
Product Identification
Product ID:SODIUM IODIDE I 131 DIAGNOSTIC CAPSULES
MSDS Date:01/01/1997
FSC:6505
NIIN:00F054702
MSDS Number: CGHNW
Responsible Party
MARYLAND HEIGHTS, MO 63043-3421
US
Emergency Phone: 314-770-7800
Info Phone: 314-770-7800/314-895-2000
Cage: FO650
Contractor
Telephone: 314-770-7800/314-895-2000
Cage: FO650
Ingredients
SODIUM IODIDE I 131 *97-4*
CAS: 7790-26-3
Fraction By Weight: <0.001%
L-CYSTINE
CAS: 56-89-3
RTECS: HA2690000
Fraction By Weight: <0.1%
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, DISODIUM PHOSPHATE
CAS: 7558-79-4
RTECS: WC4500000
Fraction By Weight: 93.6%
EPA Report Quantity: 5000 LBS
DOT Report Quantity: 5000 LBS
LACTOSE
CAS: 63-42-3
RTECS: OD9625000
Fraction By Weight: 4.7%
MAGNESIUM STEARATE
CAS: 557-04-0
RTECS: WI4390000
Fraction By Weight: 1.7%
Hazards
Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INGESTION: MAY CAUSE ASYMPTOMATIC
PHYSIOLOGICAL UPTAKE BY THYROID GLAND/OTHER TISSUES. OTHER HEALTH
RISKS CAUSED BY RADIATION EXPOSURE ARE: CANCER, LEUKEMIA, GENETIC &
TERATOGENIC EFFECTS WHICH MAY BE CAUSED WHEN LEVELS OF RADIATION
EXPOSURE ARE MUCH HIGHER THAN THOSE PERMITTED OCCUPATIONALLY.
Explanation of Carcinogenicity:NONE
First Aid
First Aid:INGESTION: NOTIFY RADIATION SAFETY PERSONNEL IMMEDIATELY.
AMOUNT OF I 131 IN THE THYROID GLAND MUST BE ASSESSED DOCUMENTED. A
THYROID BLOCKING AGENT MAY BE WARRANTED/ADMINISTERED UNDER THE
DIRECTION O F A PHYSICIAN. SKIN: WASH THOROUGHLY W/SOAP & WATER.
ALWAYS BLOT DRY. DON'T ABRADE SKIN. EYES: WASH W/WATER FOR 15
MINS/UNTIL NO MORE RADIOACTIVITY CAN BE REMOVED. OBTAIN MEDICAL
ATTENTION IN ALL CASE
Fire Fighting
Flash Point:NONFLAMMABLE
Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING & NIOSH-APPROVED
SELF CONTAINED BREATHING APPARATUS W/FULL FACEPIECE OPERATED IN THE
PRESSURE DEMAND/OTHER POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:MAY EMIT RADIOACTIVE FUMES CONTAINING I
131 WHEN HEATED TO DECOMPOSITION.
Accidental Release
Spill Release Procedures:IF A PRODUCT IS RECEIVED IN A LEAKING
CONDITION/ANY LOSS/RELEASE OF THE RADIOACTIVE CONTENTS OCCURS,
NOTIFY THE RADIATION SAFETY DEPT & MALLINCKRODT. ALL CLEANUP
OPERATIONS SHOULD BE PERFORMED ACCORDI NG TO THE STANDARD OPERATING
PROCEDURES.
Handling
Handling and Storage Precautions:STORE AT 59-85F. HANDLING TIME SHOULD
BE KEPT TO A MINIMUM. USE HANDLING DEVICES SUCH AS SYRINGE SHIELDS
& TONGS. READ PACKAGE INSERT PRIOR TO USE.
Other Precautions:BECAUSE THIS PRODUCT IS INTENDED FOR USE BY
HOSPITAL/CLINIC PATIENTS, IT IS EXPECTED TO BE TREATED BY STANDARD
WASTEWATER TREATMENT FACILITIES W/NO ADVERSE ENVIRONMENTAL IMPACTS.
RADIOACTIVE DRUGS MUS T BE HANDLED BY QUALIFIED PERSONNEL.
Exposure Controls
Respiratory Protection:NOT REQUIRED
Ventilation:NOT REQUIRED
Protective Gloves:DISPOSABLE PLASTIC, LATEX/RUBBER
Eye Protection:SAFETY GLASSES
Other Protective Equipment:LABCOAT
Work Hygienic Practices:NO SMOKING, EATING/DRINKING SHOULD BE ALLOWED
IN ANY AREA WHERE RADIOACTIVE MATERIALS ARE HANDLED/STORED.
Supplemental Safety and Health
THE VIAL CONTAINING THE DRUG SHOULD BE KEPT W/IN ITS CONTAINER/W/IN
HEAVIER SHIELDING. AVOID CONTACT W/THE RADIOACTIVE CONTENTS WHICH
WOULD CAUSE UNNECESSARY EXPOSURE TO RADIATION.
Chemical Properties
Solubility in Water:COMPLETE
Appearance and Odor:OPAQUE, WHITE GELATIN CAPSULE W/NO ODOR
Stability
Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:HEATING
Hazardous Decomposition Products:RADIOACTIVE FUMES
Disposal
Waste Disposal Methods:IF MEDICAL WASTE IS INVOLVED, SUCH AS BLOOD,
BLOOD PRODUCTS/SHARPS, THE WASTE MUST BE HANDLED AS A BIOHAZARD &
DISPOSED OF IAW/LOCAL, STATE & FEDERAL REGULATIONS. RADIOACTIVE
MATERIAL UN2982.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.